Skin Manifestations
Welcome,         Profile    Billing    Logout  
 43 Companies   40 Products   40 Products   30 Mechanisms of Action   1 Trial   293 News 


1234567»
  • ||||||||||  Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
    Enrollment change, Trial termination:  Dex/Rituxan: A Chart Review of Rituximab Plus Repeated Cycles of Dexamethasone (clinicaltrials.gov) -  Jul 16, 2018   
    P=N/A,  N=72, Terminated, 
    N=20 --> 35 | Recruiting --> Terminated N=50 --> 72 | Recruiting --> Terminated
  • ||||||||||  Trial completion, Enrollment change:  PTI PARI: Study of Immune Thrombocytopenia Pathogenesis: (clinicaltrials.gov) -  Mar 15, 2018   
    P=N/A,  N=89, Completed, 
    Trial completion date: Feb 2018 --> Dec 2018 | Trial primary completion date: Feb 2018 --> Jul 2017 Recruiting --> Completed | N=175 --> 89
  • ||||||||||  Phase classification, Trial termination, Trial primary completion date:  Honey in Chronic Immune Thrombocytopenia (clinicaltrials.gov) -  Jan 9, 2018   
    P=N/A,  N=30, Terminated, 
    Trial primary completion date: Dec 2008 --> May 2009 Phase classification: P2 --> P=N/A | Suspended --> Terminated | Trial primary completion date: Jan 2017 --> Dec 2017; problem with the candidate (investigator)
  • ||||||||||  cetirizine oral / Generic mfg.
    Enrollment change, Trial termination:  Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching (clinicaltrials.gov) -  Nov 9, 2017   
    P4,  N=3, Terminated, 
    Phase classification: P2 --> P=N/A | Suspended --> Terminated | Trial primary completion date: Jan 2017 --> Dec 2017; problem with the candidate (investigator) N=73 --> 3 | Recruiting --> Terminated; Unable to recruit patients
  • ||||||||||  Enrollment change:  Gabapentin to Treat Itch in Patients With Liver Disease (clinicaltrials.gov) -  Oct 13, 2017   
    P3,  N=15, Completed, 
    N=73 --> 3 | Recruiting --> Terminated; Unable to recruit patients N=30 --> 15
  • ||||||||||  acetylcysteine solution / Generic mfg.
    Trial completion:  NACinTTP: A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura (clinicaltrials.gov) -  Sep 20, 2017   
    P,  N=3, Completed, 
    Active, not recruiting --> Completed | N=62 --> 16 | Trial primary completion date: Jun 2017 --> Sep 2017 Enrolling by invitation --> Completed
  • ||||||||||  cyclophosphamide / Generic mfg.
    Trial completion:  Treatment of Autoimmune Thrombocytopenia (AITP) (clinicaltrials.gov) -  Jun 30, 2017   
    P1,  N=29, Completed, 
    N=10 --> 22 Recruiting --> Completed
  • ||||||||||  Enrollment change, Trial withdrawal:  Single Incision Versus Standard Laparoscopic Splenectomy (clinicaltrials.gov) -  Feb 3, 2017   
    P=N/A,  N=0, Withdrawn, 
    Initiation date: Jun 2011 --> Jun 2012 | Trial primary completion date: Jun 2013 --> Jul 2016 N=30 --> 0 | Active, not recruiting --> Withdrawn
  • ||||||||||  Promacta (eltrombopag) / Novartis
    Trial completion, Trial initiation date, Trial primary completion date:  Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP) (clinicaltrials.gov) -  Feb 2, 2017   
    P2,  N=12, Completed, 
    N=30 --> 0 | Active, not recruiting --> Withdrawn Active, not recruiting --> Completed | Initiation date: May 2009 --> Jan 2009 | Trial primary completion date: Jan 2014 --> Sep 2015
  • ||||||||||  Promacta (eltrombopag) / Novartis
    Trial primary completion date:  End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia (clinicaltrials.gov) -  Feb 2, 2017   
    P=N/A,  N=20, Recruiting, 
    Active, not recruiting --> Completed | Initiation date: May 2009 --> Jan 2009 | Trial primary completion date: Jan 2014 --> Sep 2015 Trial primary completion date: Jun 2013 --> Mar 2019
  • ||||||||||  Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
    Trial primary completion date:  Dex/Rituxan: A Chart Review of Rituximab Plus Repeated Cycles of Dexamethasone (clinicaltrials.gov) -  Jan 31, 2017   
    P=N/A,  N=50, Recruiting, 
    Trial primary completion date: Jun 2013 --> Mar 2019 Trial primary completion date: Jan 2016 --> Jun 2017
  • ||||||||||  Promacta (eltrombopag) / Novartis
    Trial completion, Trial primary completion date:  Promacta Pregnancy Registry (clinicaltrials.gov) -  Jul 25, 2016   
    P=N/A,  N=1, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Jan 2016 --> Jul 2014
  • ||||||||||  Trial primary completion date:  Honey in Chronic Immune Thrombocytopenia (clinicaltrials.gov) -  Jul 19, 2016   
    P2,  N=30, Suspended, 
    Recruiting --> Completed | Trial primary completion date: Jan 2016 --> Jul 2014 Trial primary completion date: Jan 2016 --> Jan 2017
  • ||||||||||  lovastatin / Generic mfg.
    Trial primary completion date:  NeuSTART2: Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2 (clinicaltrials.gov) -  May 9, 2016   
    P2,  N=164, Active, not recruiting, 
    Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Mar 2016 Trial primary completion date: Dec 2015 --> Dec 2016
  • ||||||||||  Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
    Trial completion, Enrollment change, Trial primary completion date, Combination therapy:  rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP (clinicaltrials.gov) -  Apr 21, 2016   
    P3,  N=123, Completed, 
    N=199 --> 0 | Recruiting --> Withdrawn Recruiting --> Completed | N=240 --> 123 | Trial primary completion date: Sep 2013 --> Dec 2013
  • ||||||||||  Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
    Trial completion, Enrollment change, Trial primary completion date, Combination therapy:  Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP) (clinicaltrials.gov) -  Apr 21, 2016   
    P3,  N=91, Completed, 
    Recruiting --> Completed | N=240 --> 123 | Trial primary completion date: Sep 2013 --> Dec 2013 Recruiting --> Completed | N=200 --> 91 | Trial primary completion date: Sep 2012 --> Aug 2013